In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses a new drug for COPD, ensifentrine (Ohtuvayre). 

This is an excerpt from our September 2024 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: 

• Article: Watch for Ensifentrine (Ohtuvayre) for COPD
• Chart: Inhaled Medications for COPD

Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. 

If you're a student, good news—students can access a free version of Pharmacist’s Letter.

Send us a text

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at [email protected].